C12H11N5O6, triclinic, P1̅ (no. 2), a = 10.4031(5) Å, b = 11.3191(5) Å, c = 13.2540(6) Å, α = 97.666(2)°, β = 102.252(2)°, γ = 110.182(2)°, V = 1394.73(11) Å3, Z = 4, Rgt(F) = 0.0348, wRref(F2) = 0.1030, T = 100 K, Dcalc = 1.530 mg m−3
C18H16N4O6, monoclinic, C2/c (no. 15), a = 28.3976(19) Å, b = 10.5649(7) Å, c = 12.1155(10) Å, β = 9...
The title compound, C16H16N4O2, crystallizes with two molecules in the asymmetric unit, one of which...
C22H19NO6, monoclinic, P21/n (no. 14), a = 9.195(4) Å, b = 17.253(5) Å, c = 12.127(5) Å, β = 95.100(...
C22H22N2O5, triclinic, P1̅ (no. 2), a = 7.592(2) Å, b = 9.835(3) Å, c = 13.579(4) Å, α = 86.600(3)°,...
C13H10F3N3O4, triclinic, P (1) over bar (no. 2), a = 7.0524(14) angstrom, b = 7.8044(16) angstrom, c...
C10H15N3O2, monoclinic, P21/n (no. 14), a = 10.9501(14) Å, b = 9.2193(9) Å, c = 11.2149(14) Å, β = 1...
The title compound, C19H18N2O2, was investigated by single crystal X-ray diffraction method. It crys...
C19H19N5O, triclinic, P1̅ (no. 2), a = 11.8865(6) Å, b = 12.6289(7) Å, c = 13.5579(7) Å, α = 74.5...
C3H2N4O4, monoclinic, P21/c (No. 14), a = 9.7013(13) Å, b = 12.0797(10) Å, c = 9.7587(7) Å, β = ...
C13H10F3N3O4, triclinic, P1̅ (no. 2), a = 7.0524(14) Å, b = 7.8044(16) Å, c = 12.954(3) Å, α = 97.93...
The title compound, 5-amino-1-(2,4,6-trichlorophenyl)-1H-pyrazole-4-carbonitrile, C10H5Cl3N4, crysta...
C22H19NO6, monoclinic, P21/n (no. 14), a = 9.055(3) Å, b = 17.601(6) Å, c = 11.817(4) Å, β = 91.361(...
The title compound, C16H16N4O2, crystallizes with two molecules in the asymmetric unit, one of which...
In the title compound, C14H17N3O3, the dihedral angle between the benzene ring and the five-membered...
C18H15FN2O2, triclinic, P1̅ (no. 2), a = 7.8272(8) Å, b = 9.6662(10) Å, c = 10.9834(12) Å, α = 107.8...
C18H16N4O6, monoclinic, C2/c (no. 15), a = 28.3976(19) Å, b = 10.5649(7) Å, c = 12.1155(10) Å, β = 9...
The title compound, C16H16N4O2, crystallizes with two molecules in the asymmetric unit, one of which...
C22H19NO6, monoclinic, P21/n (no. 14), a = 9.195(4) Å, b = 17.253(5) Å, c = 12.127(5) Å, β = 95.100(...
C22H22N2O5, triclinic, P1̅ (no. 2), a = 7.592(2) Å, b = 9.835(3) Å, c = 13.579(4) Å, α = 86.600(3)°,...
C13H10F3N3O4, triclinic, P (1) over bar (no. 2), a = 7.0524(14) angstrom, b = 7.8044(16) angstrom, c...
C10H15N3O2, monoclinic, P21/n (no. 14), a = 10.9501(14) Å, b = 9.2193(9) Å, c = 11.2149(14) Å, β = 1...
The title compound, C19H18N2O2, was investigated by single crystal X-ray diffraction method. It crys...
C19H19N5O, triclinic, P1̅ (no. 2), a = 11.8865(6) Å, b = 12.6289(7) Å, c = 13.5579(7) Å, α = 74.5...
C3H2N4O4, monoclinic, P21/c (No. 14), a = 9.7013(13) Å, b = 12.0797(10) Å, c = 9.7587(7) Å, β = ...
C13H10F3N3O4, triclinic, P1̅ (no. 2), a = 7.0524(14) Å, b = 7.8044(16) Å, c = 12.954(3) Å, α = 97.93...
The title compound, 5-amino-1-(2,4,6-trichlorophenyl)-1H-pyrazole-4-carbonitrile, C10H5Cl3N4, crysta...
C22H19NO6, monoclinic, P21/n (no. 14), a = 9.055(3) Å, b = 17.601(6) Å, c = 11.817(4) Å, β = 91.361(...
The title compound, C16H16N4O2, crystallizes with two molecules in the asymmetric unit, one of which...
In the title compound, C14H17N3O3, the dihedral angle between the benzene ring and the five-membered...
C18H15FN2O2, triclinic, P1̅ (no. 2), a = 7.8272(8) Å, b = 9.6662(10) Å, c = 10.9834(12) Å, α = 107.8...
C18H16N4O6, monoclinic, C2/c (no. 15), a = 28.3976(19) Å, b = 10.5649(7) Å, c = 12.1155(10) Å, β = 9...
The title compound, C16H16N4O2, crystallizes with two molecules in the asymmetric unit, one of which...
C22H19NO6, monoclinic, P21/n (no. 14), a = 9.195(4) Å, b = 17.253(5) Å, c = 12.127(5) Å, β = 95.100(...